Organization Overview
Historical Acquisition Tree
Alternative names
tazemetostat (Tazverik) (2020)
Carcinoma (Phase 2)
Carcinoma, Medullary (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Chordoma (Phase 2)
Hematologic Neoplasms (Phase 1)
Kidney Neoplasms (Phase 2)
Leukemia (Phase 1)
Liver Diseases (Phase 1)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Mantle-Cell (Phase 1)
Lymphoma, Non-Hodgkin (Phase 1)
Mesothelioma (Phase 2)
Myelodysplastic Syndromes (Phase 1)
Myeloproliferative Disorders (Phase 1)
Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 1)
Rhabdoid Tumor (Phase 2)
Sarcoma (Phase 3)
Sarcoma, Synovial (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)